Pharmacological insights of altered lipid metabolism in oncological, neurological, cardiovascular, and hepatic diseases
December 5, 2018
Aula Meneghetti
Department of Pharmaceutical and Pharmacological Sciences
Largo Meneghetti 2 - Padova
Agenda
14:00
Registration
14:30
Welcome and Introduction
Paolo Caliceti, Full Professor, Director of the Department of Pharmaceutical Sciences Pharmacological, University of Padua
Session1
Moderator: Marco Sandri, MD, Full Professor, Dipartimento di Scienze Biomediche, Università di Padova; Giuseppe Opocher, MD, Scientific Director Istituto Oncologico Veneto I.R.C.S.S, Padua
14.45: “Direct and indirect involvement of lipid metabolism in the physiopathology of hereditary spastic paraplegias" Giovanni Stevanin, PhD, Research Director (INSERM), Professor Ecole Pratique des Hautes Etudes, Paris
15.10: “Lipid Lowering Drugs and Inflammatory Changes: An Impact on Cardiovascular Outcomes?” Massimiliano Ruscica, PhD, Assistant Professor, Department of Pharmacological and Biomolecular Science, University of Milan.
15.35: “The role of lipid metabolism in endocrine therapy resistance of estrogen receptor positive breast cancer cells” Andrea Morandi, PhD, Fondazione Veronesi, Department of Experimental and Clinical Biomedical Sciences, University of Florence.
Coffee break
Session 2
16.00: “Lipid metabolism in the pathogenesis of Non-Alcoholic Steatohepatitis” Francesco Paolo Russo, MD. Assistant Professor, Department of Surgery, Oncology and Gastroenterology, University of Padova
Young session
16.25
Moderator: Paolo Porporato, PhD. Assistant professor, Department of Molecular Biotechnology and Health Sciences, University of Turin, Stefano Realdon, MD, Head of the Digestive Endoscopy Unit, Istituto oncologico Veneto I.R.C.S.S., Padua
16.30 “Lipid metabolism and inflammation” Alessio Menga IRCCS Istituto Tumori "Giovanni Paolo II" Bari
16.40 “SGLT-2 inhibition: experimental data on glucose and lipid metabolism”. Chiara Macchi, Department of Pharmacological and Biomolecular Science, University of Milan.
16.50 “Role of PI3K-C2A in lipid and glucose metabolism” Miriam Martini Department of Molecular Biotechnology and Health Sciences, University of Torino. Molecular Biotechnology Center
17.00 “NAFLD, NASH and liver cancer”. Martina Gambato MD. Multivisceral Transplant Unit and Gastroenterology, Padua University-Hospital
17.20 Closure
Program Contact and Meeting Logistics:
Maddalena Murari maddalena.murari@unipd.it
Daniela Strafella daniela.strafella@unipd.it
Organizing Committee and Scientific:
Sara De Martin, PhD; Nicola Ferri, PhD; Monica Montopoli, PhD; Genny Orso, PhD.
Department of Pharmaceutical and Pharmacological Sciences, University of Padova
Registration Deadline: December 2, 2018 (up to 160 seats)
link:
REGISTRATION TO THE WORKSHOP
poster
